# INTERVIEW: Widecells Group Increase Global Reach with Cryoviva Deal

- Link: https://www.directorstalkinterviews.com/interview-widecells-group-increase-global-reach-cryoviva-deal/412748062
- Published: 2018-03-26T09:45:44+01:00
- Author: Giles Arbor

**Widecells Group Plc** (LON:WDC) CEO João Andrade talks to DirectorsTalk about 
a [landmark deal](https://www.directorstalkinterviews.com/widecells-group-plc-landmark-deal-launch-cellplan-insurance-product-asia/412748060)
to launch it’s CellPlan insurance product in Asia. João explains who Cryoviva are,
the impact this deal will have, how these clients will be targeted, the reason for
a deal in Asia and talks about a changing of awareness stem cell therapy is having.

WideCells Group PLC is building an integrated stem cell services company, focused
on making stem cell treatments accessible and affordable. This is achieved through
three divisions:

The Group has three divisions:

· CellPlan: the world’s first stem cell healthcare insurance plan with financial
cover for medical treatment, travel and accommodation expenses and concierge service
to manage the treatment process.

· WideCells: The Institute of Stem Cell Technology has been established and is based
in the University of Manchester Innovation Centre to provide stem cell storage services
and focus on stem cell research and regenerative medicine. Its international cryogenics
division specialises in stem cell storage, with the Group currently offering umbilical
cord blood and tissue storage services to clients in the UK and Europe under the
brand name BabyCells.

· Wideacademy: an education and training division to promote awareness of the benefits
of stem cell storage across the global general practice community.

The Group has built an experienced senior management team that has been integral
to the development of its growth and business to date.

**Stem Cell Fast Facts:**

· Cord blood (which is taken from the umbilical cord) provides the most effective
source of stem cells for families due to it being simple, safe and painless to collect
relative to other sources of stem cells such as bone marrow – WideCells will focus
on promoting the collection and storage of cord blood.

· Since 2005, there has been a 300% increase in the number of illnesses that can
be treated using stem cells.

· 82 illnesses can currently be treated using stem cell procedures.

· Despite initial storage often costing no more than a few £thousand, actual treatment
can cost in the £hundreds of thousands

Share on: